Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, October 28, 2016
[ Fri, Oct 28th 2016
] - WOPRAI
[ Fri, Oct 28th 2016
] - WOPRAI
[ Fri, Oct 28th 2016
] - WOPRAI
[ Fri, Oct 28th 2016
] - WOPRAI
[ Fri, Oct 28th 2016
] - WOPRAI
[ Fri, Oct 28th 2016
] - WOPRAI
[ Fri, Oct 28th 2016
] - WOPRAI
[ Fri, Oct 28th 2016
] - WOPRAI
[ Fri, Oct 28th 2016
] - WOPRAI
[ Fri, Oct 28th 2016
] - WOPRAI
[ Fri, Oct 28th 2016
] - WOPRAI
[ Fri, Oct 28th 2016
] - WOPRAI
[ Fri, Oct 28th 2016
] - WOPRAI
[ Fri, Oct 28th 2016
] - WOPRAI
[ Fri, Oct 28th 2016
] - WOPRAI
[ Fri, Oct 28th 2016
] - WOPRAI
[ Fri, Oct 28th 2016
] - WOPRAI
[ Fri, Oct 28th 2016
] - WOPRAI
[ Fri, Oct 28th 2016
] - WOPRAI
[ Fri, Oct 28th 2016
] - WOPRAI
[ Fri, Oct 28th 2016
] - WOPRAI
[ Fri, Oct 28th 2016
] - WOPRAI
[ Fri, Oct 28th 2016
] - WOPRAI
[ Fri, Oct 28th 2016
] - WOPRAI
[ Fri, Oct 28th 2016
] - WOPRAI
[ Fri, Oct 28th 2016
] - WOPRAI
Matthew Kaplan Upgraded (UTHR) to Strong Buy on, Oct 28th, 2016
Matthew Kaplan of Ladenburg Thalmann, Upgraded "United Therapeutics Corporation" (UTHR) to Strong Buy on, Oct 28th, 2016.
Matthew has made no other calls on UTHR in the last 4 months.
There is 1 other peer that has a rating on UTHR. Out of the 1 peers that are also analyzing UTHR, all agrees with Matthew's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Jessica Fye of "JP Morgan" Maintained at Hold with Decreased Target to $129 on, Friday, July 29th, 2016
